Health In Tech, Inc.
Health In Tech, Inc. (HIT) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
hit · stock forecast · 0 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 0 Wall Street analysts in the past 3 months
N/A
0 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$4.00
Consensus
$4.00
+284.6% upside
Low
$4.00
Median: $4 · Last Close: $1.04
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
BearAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $0.99 | ↓ 5.00% |
1-day model range: $0.97–$1. Peak: $1 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -25.4% |
| 2028 | $1 | -34.9% |
| 2029 | $1 | -39.0% |
| 2030 | $1 | -41.0% |
| 2031 | — | -41.9% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · HIT · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|
Wall Street analysts have recently issued updated ratings on Health In Tech, Inc. (HIT) stock. Of the recent 0 rating actions, 0 were upgrades and 0 were downgrades. 0 analysts currently cover HIT.
Analyst Recommendation Trends
HIT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$32M
↓ 58.7% YoY
Revenue Next Year
$47M
↑ 44.7% YoY
EPS This Year
$0.01
EPS Next Year
$-0.06
↓ 477.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast HIT EPS of $0.01 for the current fiscal year, based on estimates from 1 analysts. The HIT revenue forecast is $32M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The HIT stock forecast is supported by two independent data sources: analyst consensus ratings from 0 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus HIT price target is $4.00 (+284.6% upside), with an analyst consensus of N/A.
The HIT short-term stock prediction for tomorrow is $0.99 (-5.00%). The HIT stock price prediction for 2027 estimates an average of $1. The HIT stock prediction for 2030 projects a range of $1–$1.
Health In Tech, Inc. trades on NASDAQ under the ticker HIT. The HIT stock outlook for 2027 is broadly mixed, supported by a N/A consensus among 0% of covering analysts.
Frequently asked questions
HIT forecast · 8 questionsAccording to 0 Wall Street analysts, the average 12-month HIT price target is $4.00, with a high forecast of $4.00 and a low of $4.00. The median price target is shown in the chart above when available. This implies +284.6% potential upside from the current price of $1.04.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.